“Formulation and Optimization of Liquisolid Tablet for Improving the Dissolution Profile of Rivaroxaban by Using DoE Approachand Antithrombic Activity”. Journal of Carcinogenesis 24, no. 3s (October 10, 2025): 812–830. Accessed December 17, 2025. https://carcinogenesis.com/index.php/JOC/article/view/1715.